Transcranial Magnetic Stimulation (TMS) - Behavioral Health Policy
Customize your policy alerts
Sign up for Health-New-England Policy UM917POL alerts
Get alerted when Policy UM917POL changes without checking for updates manually.
Monitor payer policy activity
This policy governs prior authorization and medical-necessity review for initial and repeat TMS treatment of major depressive disorder for Health New England Commercial and Medicare Advantage members. Commercial members are reviewed under the policy criteria, while Medicare members follow LCD L33398; Medicaid/BeHealthy medical-necessity review is performed by MBHP.
The psychopharmacologic-resistance criteria were updated to require two or more medication trials from at least two different antidepressant classes during the current depressive episode.
The policy clarified that approved TMS services are authorized for 12 weeks from the requested start date.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.